These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6301414

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
    Wilmes E, Wolf H, Deinhardt F, Naumann HH.
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
    [Abstract] [Full Text] [Related]

  • 23. Clinical evaluation of EBV serology in American patients with nasopharyngeal carcinoma.
    Pearson GR, Coates HL, Neel HB, Levine P, Ablashi D, Easton J.
    IARC Sci Publ (1971); 1978 Jan; (20):439-48. PubMed ID: 215526
    [Abstract] [Full Text] [Related]

  • 24. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.
    Shimakage M, Ikegami N, Chatani M, Yoshino K, Sato T.
    Biken J; 1987 Jun; 30(2):45-51. PubMed ID: 2830879
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.
    Neel HB, Pearson GR, Taylor WF.
    Ann Otol Rhinol Laryngol; 1984 Jun; 93(5 Pt 1):477-82. PubMed ID: 6093669
    [Abstract] [Full Text] [Related]

  • 27. Histological types of nasopharyngeal carcinoma as compared to EBV serology.
    Krueger GR, Kottaridis SD, Wolf H, Ablashi DV, Sesterhenn K, Bertram G.
    Anticancer Res; 1981 Jun; 1(4):187-94. PubMed ID: 6285799
    [Abstract] [Full Text] [Related]

  • 28. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA].
    Cai YL, Zheng YM, Cheng JR, Wang W, Zhang YN, Wang WH, Wu YS, Zhong WM, Li J, Mo YK.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):509-11. PubMed ID: 20335122
    [Abstract] [Full Text] [Related]

  • 29. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
    Hewetson JF, Levine PH, Neubauer RH, Rabin H.
    Int J Cancer; 1982 Nov 15; 30(5):581-5. PubMed ID: 6295966
    [Abstract] [Full Text] [Related]

  • 30. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
    Chow KC, Ma J, Lin LS, Chi KH, Yen SH, Liu SM, Liu WT, Chen WK, Chang TH, Chen KY.
    Cancer Epidemiol Biomarkers Prev; 1997 May 15; 6(5):363-8. PubMed ID: 9149897
    [Abstract] [Full Text] [Related]

  • 31. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M.
    J Clin Virol; 2008 Feb 15; 41(2):96-103. PubMed ID: 18024156
    [Abstract] [Full Text] [Related]

  • 32. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
    Hu B, Hong G, Li Z, Xu J, Zhu Z, Li L.
    Biotechnol Appl Biochem; 2007 May 15; 47(Pt 1):59-69. PubMed ID: 17129209
    [Abstract] [Full Text] [Related]

  • 33. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
    Liu Y, Huang Q, Liu W, Liu Q, Jia W, Chang E, Chen F, Liu Z, Guo X, Mo H, Chen J, Rao D, Ye W, Cao S, Hong M.
    Int J Cancer; 2012 Jul 15; 131(2):406-16. PubMed ID: 21866545
    [Abstract] [Full Text] [Related]

  • 34. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.
    Rowe M, Finke J, Szigeti R, Klein G.
    J Gen Virol; 1988 Jun 15; 69 ( Pt 6)():1217-28. PubMed ID: 2838572
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.